Dr. Michael J. Cima is the David H. Koch Professor of Engineering and Associate Dean of Innovation for the School of Engineering at MIT. He is a cofounder of the Deshpande spinout company Taris Biomedical, a urology products company acquired by Johnson & Johnson in 2019. He also is cofounder of MicroChips Inc., a developer of microelectronic-based drug delivery and diagnostic systems, and a cofounder and Director at T2 Biosystems, a medical diagnostics company.
Michael is author or co-author of over 250 peer-reviewed scientific publications and 58 US patents, and a recognized expert in materials processing. He is actively involved in materials and engineered systems for treatments for cancer, metabolic diseases, trauma, and urological disorders. His research concerns advanced forming technology such as for complex macro and micro devices, colloid science, MEMS and other micro components for medical devices used for drug delivery and diagnostics, and high-throughput development methods for formulations of materials and pharmaceutical formulations. He is a co-inventor of MIT’s three-dimensional printing process.
He earned a B.S. in Chemistry (phi beta kappa) and a Ph.D. in Chemical Engineering, both from the University of California at Berkeley. Michael was elected to the National Academy of Engineering in 2011, and appointed Faculty Director in 2009 of the Lemelson-MIT Program, a program to inspire youth to be inventive.